345 related articles for article (PubMed ID: 17721198)
1. Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion.
Hayes MM; Peterse JL; Yavuz E; Vischer GH; Eusebi V
Am J Surg Pathol; 2007 Sep; 31(9):1414-9. PubMed ID: 17721198
[TBL] [Abstract][Full Text] [Related]
2. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
[TBL] [Abstract][Full Text] [Related]
4. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
[TBL] [Abstract][Full Text] [Related]
5. High-grade carcinomas of the breast showing patterns of mixed ductal and myoepithelial differentiation (including myoepithelial cell-rich carcinoma of the breast).
Coyne JD; Dervan PA; Barr L
Histopathology; 2004 Jun; 44(6):580-4. PubMed ID: 15186273
[TBL] [Abstract][Full Text] [Related]
6. Breast intracystic papillary carcinoma: an update.
Calderaro J; Espie M; Duclos J; Giachetti S; Wehrer D; Sandid W; Cahen-Doidy L; Albiter M; Janin A; de Roquancourt A
Breast J; 2009; 15(6):639-44. PubMed ID: 19735389
[TBL] [Abstract][Full Text] [Related]
7. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
Man YG; Shen T; Weisz J; Berg PE; Schwartz AM; Mulshine JL; Sang QX; Nieburgs HE
Cancer Detect Prev; 2005; 29(4):323-31. PubMed ID: 16122886
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
9. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
10. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.
Skalova A; Ryska A; Kajo K; Di Palma S; Kinkor Z; Michal M
Histopathology; 2005 Jan; 46(1):43-9. PubMed ID: 15656885
[TBL] [Abstract][Full Text] [Related]
11. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
12. [Malignant myoepithelioma associated with in situ and invasive ductal carcinoma. Description of a case and review of the literature].
Scarpellini F; Usellini L; Foschini MP
Pathologica; 1997 Aug; 89(4):420-4. PubMed ID: 9471611
[TBL] [Abstract][Full Text] [Related]
13. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
Esposito NN; Dabbs DJ; Bhargava R
Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
[TBL] [Abstract][Full Text] [Related]
14. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
15. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
16. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
17. [Primary squamous cell carcinoma of the breast: a case report].
Megha T; D'Amuri A; Benvenuto A; De Santi MM; De Luca F; Civitelli S
Pathologica; 2004 Apr; 96(2):45-8. PubMed ID: 15449446
[TBL] [Abstract][Full Text] [Related]
18. Cystic hypersecretory (in situ) carcinoma of the breast: a clinicopathologic and immunohistochemical characterization of 10 cases with clinical follow-up.
D'Alfonso TM; Ginter PS; Liu YF; Shin SJ
Am J Surg Pathol; 2014 Jan; 38(1):45-53. PubMed ID: 24121179
[TBL] [Abstract][Full Text] [Related]
19. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic carcinoma with osteoclastic giant cells of the breast: immunohistochemical differentiation between coexisting neoplastic and reactive giant cells.
Kurokawa K; Mouri Y; Asano A; Kamei K; Iwata Y; Isogai M; Saga S; Ichihara S
Pathol Int; 2009 Feb; 59(2):91-7. PubMed ID: 19154262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]